Patent applications and USPTO patent grants for Neuronyx Inc..The latest application filed is for "treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro".
Patent | Date |
---|---|
Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro App 20090053183 - Kopen; Gene ;   et al. | 2009-02-26 |
Cell populations which co-express CD49c and CD90 App 20070264232 - Ho; Tony W. ;   et al. | 2007-11-15 |
Cell populations which co-express CD49c and CD90 App 20070231309 - Ho; Tony W. ;   et al. | 2007-10-04 |
Cell populations which co-express CD49c and CD90 App 20050233452 - Ho, Tony W. ;   et al. | 2005-10-20 |
Cell populations which co-express CD49c and CD90 App 20040058412 - Ho, Tony W. ;   et al. | 2004-03-25 |
Novel synthetic gangliosides App 20020072502 - Ho, Tony W. | 2002-06-13 |
SEC | 0001118565 | NEURONYX INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.